Citation: Ca. Roldan et al., Prevalence and diagnostic value of precordial murmurs for valvular regurgitation in obese patients treated with dexfenfluramine, AM J CARD, 86(5), 2000, pp. 535-539
Authors:
Ecder, T
Edelstein, CL
Chapman, AB
Johnson, AM
Tison, L
Gill, EA
Brosnahan, GM
Schrier, RW
Citation: T. Ecder et al., Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease, NEPH DIAL T, 14(5), 1999, pp. 1113-1116
Authors:
Zimmerman, GA
Albertine, KH
Carveth, HJ
Gill, EA
Grissom, CK
Hoidal, JR
Imaizumi, T
Maloney, CG
McIntyre, TM
Michael, JR
Orme, JF
Prescott, SM
Topham, MS
Citation: Ga. Zimmerman et al., Endothelial activation in ARDS, CHEST, 116(1), 1999, pp. 18S-24S
Authors:
Shively, BK
Roldan, CA
Gill, EA
Najarian, T
Loar, SB
Citation: Bk. Shively et al., Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine, CIRCULATION, 100(21), 1999, pp. 2161-2167
Authors:
Lowes, BD
Gill, EA
Abraham, WT
Larrain, JR
Robertson, AD
Bristow, MR
Gilbert, EM
Citation: Bd. Lowes et al., Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure, AM J CARD, 83(8), 1999, pp. 1201-1205